We are monitoring the impact of COVID-19 on North America Psoriasis Drugs Market Get in touch with us for detailed analysis Know More
Share on

North America Psoriasis Drugs Market Research Report - Segmented By Drug Type, Route of Administration, Target, & Country (The United States, Canada & Rest of North America) - industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1636
Pages: 140

North America Psoriasis Drugs Market Size (2022 to 2027)

The North America Psoriasis Drugs Market size is forecasted to grow USD 5.33 billion by 2027 from USD 3.82 billion in 2022, registering a CAGR of 6.91% from 2022 to 2027.

The North American psoriasis drugs market is forecasted to be driven by the rising prevalence of psoriasis patients. The immune system, genetics, and the environment all have a role in the development of psoriasis. Climate change, stress, and an unhealthy lifestyle have increased people living with psoriasis in recent years. The market is growing due to an increase in psoriasis research and pipeline medications and an increase in disease burden and demand for psoriasis treatments in this region. Patients who are afraid of needles now have options due to new medicines that may be taken orally. The disease's treatment focuses mostly on reducing inflammation and clearing the skin. Topical therapy is utilized for mild to severe psoriasis and is typically done on an individual basis. It is typically considerably more successful and safer to combine a biologic with a faster-acting systemic medication, such as cyclosporine. Many doctors prescribe combination treatments because they provide faster, longer-lasting benefits with fewer side effects and need lower doses, which is likely to drive the psoriasis drugs market in North America.

Furthermore, the growing prevalence of plaque psoriasis and psoriatic arthritis, the large pipeline of biologic and biosimilars medicines, favorable reimbursement policies, and increased prescription volume of biologic drugs contribute to the psoriasis treatment market's growth. The region's dominance is anticipated to persist during the forecast period due to high adoption of biological treatments, high R&D investment by regional companies on clinical trials for psoriasis management, and growth in long-term and preventive healthcare facilities.

However, factors such as the high cost of psoriasis therapy may restrict the North American psoriasis drugs market growth. In addition, the severe side effects of most existing medications are likely to hamper market expansion. Because people are avoiding dermatology clinics for psoriasis treatment, the market for psoriasis therapy is anticipated to slow down. Apart from limits on non-emergency medical treatments, new government laws in this region have led some businesses in the dermatological medication industry to stop operations, affecting the expansion of the market.

This research report on the North America Psoriasis Drugs Market has been segmented and sub-segmented into the following categories:

By Drug Type:

  • Pharmaceuticals
  • Biopharmaceuticals

By Route of Administration: 

  • Topical
  • Systemic
    • Oral
    • Intravenous
    • Others

By Target: 

  • Tumour Necrosis Factor (TNF)
  • Phosphodiesterase Type 4 (PDE4)
  • Interleukin

By Country: 

  • The United States
  • Canada
  • Rest of North America

During the forecast period, North America is likely to lead the psoriasis market. Because of the high incidence of psoriasis in North America, the United States has the highest market share. Psoriasis Prevalence among Children and Adolescents in the United States Furthermore established healthcare infrastructure, strong treatment acceptance, significant manufacturers, rising psoriasis incidence, high treatment adoption, significant drug manufacturers, and favorable drug manufacturers government efforts are boosting market expansion. All of these reasons are likely to boost the market in the US. In addition, the rising prevalence of psoriasis in North American countries is anticipated to increase demand for new and effective treatment options for psoriasis management. According to the National Psoriasis Foundation, psoriasis affects around 8 million people in the United States. People living with Psoriasis would have easier access to medical treatment due to robust healthcare reforms in the United States, which will drive market growth during the forecast period.

KEY MARKET PLAYERS:

A few of the noteworthy players operating in the North America psoriasis drugs market profiled in this report are Johnson & Johnson (USA), Novartis International AG (Switzerland), Pfizer Inc (USA), Merck, and Co. Inc (USA), Celgene Corporation (USA), Janssen Biotech Inc (USA), Stiefel Laboratories Inc (USA), Takeda Pharmaceutical Company Limited (Japan), Amgen (USA), and AbbVie (USA).

1.Introduction                

                1.1 Market Definition  

                1.2 Study Deliverables

                1.3 Base Currency, Base Year and Forecast Periods                                  

                1.4 General Study Assumptions      

2. Research Methodology                         

                2.1 Introduction             

                2.2 Research Phases    

                                2.2.1 Secondary Research

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling    

                                2.2.4 Expert Validation

                2.3 Analysis Design       

                2.4 Study Timeline        

3. Overview                     

                3.1 Executive Summary      

                3.2 Key Inferences       

                3.3 Epidemology            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                  

                4.1 Market Drivers        

                4.2 Market Restraints  

                4.3 Key Challenges       

                4.4 Current Opportunities in the Market            

5. Market Segmentation                            

                5.1 Drug Type 

                                5.1.1 Introduction 

                                5.1.2 Pharmaceuticals 

                                5.1.3 Biopharmaceuticals   

                                5.1.4  Y-o-Y Growth Analysis, By Drug Type        

                                5.1.5  Market Attractiveness Analysis, By Drug Type           

                                5.1.6  Market Share Analysis, By Drug Type       

                5.2 Route of Administration     

                                5.2.1 Introduction 

                                5.2.2 Topical    

                                5.2.3 Systemic

              5.2.3.1 Oral        

              5.2.3.2 Intravenous        

              5.2.3.3 Other     

                                5.2.4  Y-o-Y Growth Analysis, By Route of Administration             

                                5.2.5  Market Attractiveness Analysis, By Route of Administration 

                                5.2.6  Market Share Analysis, By Route of Administration         

                5.3 Target         

                                5.3.1 Introduction 

                                5.3.2 Tumour Necrosis Factor (TNF)      

                                5.3.3 Phosphodiesterase Type 4 (PDE4)                                

                                5.3.4 Interleukin    

                                5.3.5 Others    

                                5.3.6  Y-o-Y Growth Analysis, By Target                                 

                                5.3.7  Market Attractiveness Analysis, By Target                  

                                5.3.8  Market Share Analysis, By Target                                 

6. Geographical Analysis                            

                6.1 Introduction             

                                6.1.1 Regional Trends  

                                6.1.2 Impact Analysis   

                                6.1.3 Y-o-Y Growth Analysis      

      6.1.3.1 By Geographical Area                     

      6.1.3.2 By Product                           

      6.1.3.3 By Type                 

      6.1.3.4 By Application                    

      6.1.3.5 By Indication                       

                                6.1.4  Market Attractiveness Analysis   

      6.1.4.1 By Geographical Area                     

      6.1.4.2 By Product                           

      6.1.4.3 By Type                 

      6.1.4.4 By Application                    

      6.1.4.5 By Indication                       

                                6.1.5  Market Share Analysis    

      6.1.5.1 By Geographical Area                     

      6.1.5.2 By Product                           

      6.1.5.3 By Type                 

      6.1.5.4 By Application                    

      6.1.5.5 By Indication                       

                6.2 United States          

                6.3 Canada       

7.Strategic Analysis                      

                7.1 PESTLE analysis       

                                7.1.1 Political   

                                7.1.2 Economic                                 

                                7.1.3 Social       

                                7.1.4 Technological       

                                7.1.5 Legal

                                7.1.6 Environmental     

                7.2 Porter’s Five analysis            

                                7.2.1 Bargaining Power of Suppliers      

                                7.2.2 Bargaining Power of Consumers  

                                7.2.3 Threat of New Entrants   

                                7.2.4 Threat of Substitute Products and Services             

                                7.2.5 Competitive Rivalry within the Industry   

8.Market Leaders' Analysis                       

                8.1 Johnson & Johnson       

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis 

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments     

                                8.1.5 SWOT analysis     

                                8.1.6 Analyst View

                8.2 Novartis International AG  

                8.3 Pfizer Inc   

                8.4 Merck and Co. Inc  

                8.5 Celgene Corporation            

                8.6 Janssen Biotech Inc               

                8.7 Stiefel Laboratories Inc        

                8.8 Takeda Pharmaceutical Company Limited   

                8.9 Amgen       

                8.10 AbbVie     

9.Competitive Landscape                          

                9.1 Market share analysis          

                9.2 Merger and Acquisition Analysis     

                9.3 Agreements, collaborations and Joint Ventures                  

                9.4 New Product Launches       

10.Market Outlook and Investment Opportunities                        

Appendix                         

                a) List of Tables      

                b) List of Figures            

  1. North America Psoriasis Drugs Market, By Systemic, From 2022 - 2027 (USD Billion)
  2. North America Oral Systemic Route Market, By Region, From 2022 - 2027 (USD Billion)
  3. North America Intravenous Systemic Route Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Others Systemic Route Market, By Region, From 2022 - 2027 (USD Billion)
  5. United States Psoriasis Drugs Market, By Systemic, From 2022 - 2027 (USD Billion)
  6. Canada Psoriasis Drugs Market, By Systemic, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample